Approvals & regulatory · first seen yesterday, updated yesterday
STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks
An FDA advisory panel has endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer.
Summary from STAT News.